510(k) Report

PMA · Approved

Recalled · Class II · 2015

Pro-Trac II Tacrolimus Elisa Kit

P970025PMAApproved Apr 27, 1999666-day reviewClass II21 CFR 862.1678Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DiaSorin, Inc. · MLM Enzyme Immunoassay, Tracrolimus

Approved on Apr 27, 1999 through premarket approval, which rests on the device’s own clinical evidence after a 666-day review. It has been recalled 2 times.

Decided
Apr 27, 1999
Review
666 days
Class
Class II
Product code
MLM
Recalls
2

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

FIG. 1 — Lineage of P970025Source: FDA PMA database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MLM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MLM device

  1. #1 K203833 Tacrolimus Assay Kitscore 5.0 · 2 generations · no Class I recall
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 16, 2015Class IIZ-1464-2015Under Investigation by firmInstability in the PRO-Trac II Tacrolimus ELISA kit which may cause falsely elevated patient results.
Apr 12, 2004Not classifiedZ-0702-05OtherThe software program written for use in the automated microtiter plate reader (Bio-Tek ELx800) for use with the Pro-Trac II Tacrolimus ELISA kit was found to be faulty. Assay software program did not include the Calibrator Zero OD…

No ancestor or descendant has a Class I recall.

How does its category compare?

All MLM devices

MLM Enzyme Immunoassay, Tracrolimus: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MLM

1in 2023

2007: 22013: 12015: 12018: 12023: 1
2007high 2 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MLM

Too few MLM 510(k)s in any year since 2007 to give a median.

Recalls per year · MLM

1in 2013

2010: 22012: 12013: 12026 (partial year): 1
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MLM

8in 2025

2007: 42010: 52011: 42012: 312013: 752014: 62015: 12016: 22017: 22018: 262019: 72020: 42021: 12022: 232023: 542024: 622025: 8
2007high 75 (2013) · low 0 (2008)2025

MAUDE reports naming product code MLM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—04
20080—00
20090—00
20100—25
20110—04
20120—131
20131—175
20140—06
20151—01
20160—02
20170—02
20181—026
20190—07
20200—04
20210—01
20220—023
20231—054
20240—062
20250—08
20260—1—
Cite this page

510(k) Report. “P970025: Pro-Trac II Tacrolimus Elisa Kit.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P970025

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026